Brent Kleintop
About Brent Kleintop
Brent Kleintop is the Executive Director and Head of Chemical Development Analytical at Bristol-Myers Squibb, with extensive experience in analytical chemistry and leadership in pharmaceutical development.
Company
Brent Kleintop is currently working at Bristol-Myers Squibb as the Executive Director, Head of Chemical Development Analytical. In this role, he leads various chemical development activities and oversees a team specializing in analytical chemistry.
Title
Brent Kleintop holds the title of Executive Director, Head of Chemical Development Analytical at Bristol-Myers Squibb. He manages scientific activities, coordinates budgets, and supports departmental collaborations.
Education and Expertise
Brent Kleintop received his Ph.D. in Analytical Chemistry from the University of Florida. He also holds a B.A. in Chemistry from Wittenberg University. His expertise includes chromatographic techniques such as HPLC, UPLC, GC, chiral, SFC, CE, and Mass Spectrometry.
Background
Brent Kleintop has extensive experience in the pharmaceutical industry. He was a Senior Research Scientist at Wyeth Pharmaceuticals from 1994 to 1996 and an Applications Chemist at Thermo Finnigan from 1993 to 1994. He has considerable experience in analytical method development, structure elucidation, health authority interactions, and technology transfer.
Achievements
Brent Kleintop received the 2014 Jack Grebb Leadership Award for excellence in leadership at Bristol-Myers Squibb. He served as Chair of the Analytical Leadership Group and is a Board of Directors member of the IQ Consortium. He was also a member of the 2015-2020 Expert Committee for USP General Chapters on Chemical Analysis.